Overview

Injecto Polymers Limited’s ₹56.12 crore SME IPO has already run its full course: subscription closed September 16, allotment finalised September 17, and the stock listed on BSE SME on September 21, 2026. If you’re checking Injecto Polymers IPO allotment status now, the good news is there’s nothing left to guess, allotment, refunds, and the actual listing outcome are all confirmed. This piece covers the full timeline, how to check your allotment, what the Injecto Polymers IPO GMP actually signalled beforehand, and what really happened on listing day.

Injecto Polymers IPO Overview & Key Highlights

Injecto Polymers manufactures polymer-based packaging products, including high-denier fabrics for heavy-duty applications, and reported revenue of approximately ₹375.53 crore with strong recent growth, revenue up around 138.5% and profit up around 82.7% year-on-year heading into the issue. The company plans to use IPO proceeds mainly for debt repayment and capacity expansion at its Unit I facility in West Bengal, alongside general corporate purposes.

Key Details: Issue Size, Price Band, and Lot Size

Detail	Information
Issue Size	₹56.12 crore (entirely fresh issue)
Price Band	₹98 to ₹100 per share
Lot Size	1,200 shares
Minimum Retail Investment	₹2,40,000 (2 lots, 2,400 shares)
Listing At	BSE SME
Registrar	Integrated Registry Management Services Pvt. Ltd.
Lead Manager	Indcap Advisors Pvt. Ltd.
Market Maker	CapitalSquare Financial Services Pvt. Ltd.

Injecto Polymers IPO Timeline & Subscription Summary

Event	Date
IPO Open Date	September 11, 2026
IPO Close Date	September 16, 2026
Allotment Date	September 17, 2026
Refund Initiation	September 18, 2026
Credit of Shares to Demat	September 18, 2026
Listing Date	September 21, 2026

The issue closed with an overall subscription of roughly 1.2 to 1.3 times. Figures vary slightly by tracking source, with retail investors subscribing around 1.28 times their portion, NII coming in near 1.05 times, and QIB leading at roughly 1.57 times. This was a modestly subscribed SME issue rather than a heavily oversubscribed one, and modest subscription combined with a flat Injecto Polymers IPO expected gain reading from the grey market both pointed toward a lukewarm debut rather than a strong one.

Injecto Polymers IPO Allotment Status: Is It Out?

Yes. The basis of allotment was finalised on September 17, 2026. If you applied, your Injecto Polymers IPO allotment status is available now through the registrar or BSE.

How to Check Allotment Status on the Registrar Portal (Integrated Registry)

Visit Integrated Registry Management Services’ allotment status page, select “Injecto Polymers Limited” from the IPO dropdown, and enter your PAN, application number, or demat account details to check your Injecto Polymers IPO status check online.

How to Check Allotment Status on BSE SME Portal

Visit BSE’s IPO allotment status page, select the issue type as “Equity,” choose “Injecto Polymers” from the dropdown, and search using your PAN or application number.

What to Do If Shares Are Not Allotted? (Refund Process)

Refunds and ASBA fund unblocking for applicants who didn’t receive an allotment were initiated on September 18, 2026, the same date allotted shares were credited to successful applicants’ demat accounts. If a refund hasn’t reflected, checking with your bank or the registrar directly is the next step.

Injecto Polymers IPO GMP (Grey Market Premium) Today

The Injecto Polymers IPO GMP stayed flat at ₹0 through essentially the entire tracking period, from before the issue opened right through to the close of subscription on September 16. A GMP sitting at zero for this long is a fairly clear signal of muted grey market interest, and it turned out to be an accurate one.

Estimated Listing Price & Profit/Loss Expectations Based on GMP

With GMP at ₹0 against the ₹100 upper price band, the grey market was effectively pricing the Injecto Polymers IPO listing price at or near the issue price, with no expected listing gain built in. That’s exactly what played out: shares listed at ₹99, a 1% discount to the ₹100 issue price, according to reporting after the debut. Investors who were hoping the Injecto Polymers IPO expected gain would follow the pattern of a premium SME listing didn’t see that materialise here, the flat GMP throughout the subscription window was the more reliable signal, and the actual Injecto Polymers IPO listing price confirmed it.

Listing Expectations & Strategy for Allottees

What to Expect on Listing Day (BSE SME)

Injecto Polymers listed at ₹99 on BSE SME, a 1% discount to its ₹100 issue price. The stock weakened further during the session, trading down to around ₹94.25 at one point, a 5.75% discount to the issue price and roughly 4.80% below the listing price itself, with the day’s range spanning a high of ₹100 and a low of ₹94.05. Around 14.40 lakh shares changed hands. Promoter and promoter-group holding was diluted to roughly 54% post-issue from about 74% before the IPO.

Post-Listing Investment Strategy: Hold or Exit?

For allottees, the decision now comes down to the same fundamentals that mattered before the IPO rather than the listing-day price alone: the company’s revenue and profit growth trajectory, how the debt-repayment and capacity-expansion plans progress, and whether the current price offers a reasonable entry relative to the business’s actual prospects. A discount listing doesn’t automatically mean the business is troubled, and a strong listing doesn’t automatically validate a business either; reviewing the company’s own financials and growth plans matters more than reacting purely to the debut-day price move.

Sources

• Business Standard: BSE SME Injecto Polymers loses its grip after listing
• Integrated Registry Management Services: IPO Allotment Status
• BSE India: IPO Allotment Status